Animal Blood & Blood Components

Global Animal Blood & Blood Components Market to Reach US$263.2 Million by 2030

The global market for Animal Blood & Blood Components estimated at US$158.2 Million in the year 2024, is expected to reach US$263.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Animal Blood Components, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$155.7 Million by the end of the analysis period. Growth in the Animal Whole Blood segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.6 Million While China is Forecast to Grow at 8.5% CAGR

The Animal Blood & Blood Components market in the U.S. is estimated at US$41.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$41.8 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Animal Blood & Blood Components Market - Key Trends & Drivers Summarized

Why Is Demand for Animal Blood & Blood Components Increasing Across Various Industries?

The demand for animal blood and its components is rising across multiple industries due to its wide-ranging applications in pharmaceuticals, animal feed, food processing, and diagnostics. The increasing use of animal blood derivatives such as plasma, hemoglobin, and serum proteins in the production of vaccines, therapeutic products, and biopharmaceuticals is a key factor driving market growth. The animal feed industry has also emerged as a significant consumer, with blood meal and plasma proteins being used as high-protein dietary supplements to enhance livestock nutrition and growth. In addition, the food processing industry is incorporating animal blood components in the production of functional foods and nutritional supplements, leveraging their rich amino acid and protein content. The growing awareness of sustainable resource utilization is further encouraging industries to explore innovative applications of animal blood by-products, reducing waste and maximizing value from animal processing.

How Are Technological Advancements Driving Innovation in the Market?

Technological advancements in processing and separation techniques are revolutionizing the production and application of animal blood components. Innovations in fractionation and purification processes are enabling the extraction of high-value proteins and bioactive compounds with enhanced functional properties, making them suitable for specialized applications in biotechnology and pharmaceuticals. The adoption of advanced sterilization and preservation technologies is also improving the shelf life and stability of blood-derived products, ensuring their quality and efficacy for end-users. Additionally, research in biotechnology and molecular biology is facilitating the development of novel products such as immunoglobulin-rich plasma and bioactive peptides derived from animal blood, offering potential benefits for immune health, wound healing, and nutraceutical applications. As these technological advancements continue to evolve, manufacturers are focusing on improving product consistency, reducing processing costs, and enhancing safety standards to meet regulatory requirements across different regions.

What Challenges and Opportunities Exist in the Animal Blood & Blood Components Market?

The animal blood and blood components market faces several challenges, including regulatory hurdles, ethical concerns, and variability in raw material supply. Stringent regulatory frameworks governing the collection, processing, and use of animal-derived materials, particularly in the food and pharmaceutical industries, present compliance challenges for market players. Ethical concerns related to animal welfare and the sourcing of blood products have also prompted industry stakeholders to adopt more transparent and sustainable sourcing practices. Additionally, the potential risks of contamination and disease transmission require rigorous quality control measures, further adding to operational complexities. However, these challenges present opportunities for innovation and market differentiation. The increasing focus on alternative protein sources, growing demand for clean-label and sustainable ingredients, and the expansion of research in biomaterials and regenerative medicine offer promising growth avenues for animal blood-derived products. Companies investing in eco-friendly processing technologies and robust traceability systems are well-positioned to capitalize on emerging opportunities in this evolving market.

What Are the Key Factors Driving Growth in the Animal Blood & Blood Components Market?

The growth in the Animal Blood & Blood Components market is driven by several factors, including the rising demand for high-protein animal feed, expanding applications in pharmaceuticals, and increasing utilization in food processing. The growing global population and the rising need for efficient livestock production are fueling the demand for blood-based feed additives that enhance animal health and productivity. The pharmaceutical industry`s increasing reliance on blood-derived proteins for vaccine production, cell culture media, and biopharmaceutical development is another major growth driver. Additionally, the growing trend of functional foods and dietary supplements incorporating animal blood components is contributing to market expansion. Government initiatives promoting sustainable resource utilization and advancements in processing technologies are expected to further accelerate market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Animal Blood & Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Animal Blood Components, Animal Whole Blood); Animal Size (Large Animals, Small Animals); Application (Anemia Application, Surgery Application, Bleeding Disorders Application, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

• Animal Technologies, Inc.
• Biowest SAS
• Bovogen Biologicals Pty Ltd.
• Kraeber & Co GmbH
• Lake Immunogenics, Inc.
• LAMPIRE Biological Laboratories, Inc.
• PAN-Biotech GmbH
• Pel-Freez, LLC
• Rocky Mountain Biologicals, LLC
• Serana Europe GmbH
• TCS Biosciences Ltd.
• Thermo Fisher Scientific, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.